Skip to main content

IDENTIFICACION Y CARACTERIZACION DE CELULAS T RESTRINGIDAS A EPCR

PGC2018-094894-B-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento Científico y Tecnológico del Sistema de I+D+i
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D (Excelencia / Generación de Conocimiento)
Call year 2018
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION MIGUEL SERVET

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Structural vulnerability in EPCR suggests functional modulation

  • Erausquin, Elena
  • Rodríguez-Fernández, Adela
  • Rodríguez-Lumbreras, Luis Ángel
  • Fernández-Recio, Juan
  • Dichiara-Rodríguez, María Gilda
  • López-Sagaseta, Jacinto
The endothelial protein C receptor (EPCR) is a fundamental component of the vascular system in mammals due to its contribution in maintaining blood in a non-prothrombotic state, which is crucial for overall life development. It accomplishes this by enhancing the conversion of protein C (PC) into the anticoagulant activated protein C (APC), with this property being dependent on a known EPCR conformation that enables direct interaction with PC/APC. In this study, we report a previously unidentified conformation of EPCR whereby Tyr154, critical for PC/APC binding, shows a striking non-canonical configuration. This unconventional form is incompatible with PC/APC binding, and reveals, for the first time, a region of structural vulnerability and potential modulation in EPCR. The identification of this malleability enhances our understanding of this receptor, prompting inquiries into the interplay between its plasticity and function, as well as its significance within the broader framework of EPCR's biology, which extends to immune conditions., This work was supported by the Ministry of Science and Innovation (Government of Spain): grants Ramón y Cajal RYC-2017-21683 and Generación de Conocimiento PGC2018-094894-B-I00 to JLS and PID2019-110167RB-I00 to JFR. At the time of the study EEA was a receptor of a predoctoral fellowship "Doctorados Industriales" Gobierno de Navarra (0011-1408-2021-000000). We thank the staff of XALOC beamline at ALBA Synchrotron for their assistance with X-ray diffraction data collection., Peer reviewed
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Identification of a broad lipid repertoire associated to the endothelial cell protein C receptor (EPCR)

  • Erausquin, Elena
  • Morán-Garrido, María
  • Sáiz, Jorge
  • Barbas, Coral
  • Dichiara-Rodríguez, Gilda
  • Urdiciain Ezpeleta, Alejandro
  • López Sagaseta, Jacinto
Evidence is mounting that the nature of the lipid bound to the endothelial cell protein C receptor (EPCR) has an impact on its biological roles, as observed in anticoagulation and more recently, in autoimmune disease. Phosphatidylethanolamine and phosphatidylcholine species dominate the EPCR lipid cargo, yet, the extent of diversity in the EPCR-associated lipid repertoire is still unknown and remains to be uncovered. We undertook mass spectrometry analyses to decipher the EPCR lipidome, and identified species not yet described as EPCR ligands, such as phosphatidylinositols and phosphatidylserines. Remarkably, we found further, more structurally divergent lipids classes, represented by ceramides and sphingomyelins, both in less abundant quantities. In support of our mass spectrometry results and previous studies, high-resolution crystal structures of EPCR in three different space groups point to a prevalent diacyl phospholipid moiety in EPCR¿s pocket but a mobile and ambiguous lipid polar head group. In sum, these studies indicate that EPCR can associate with varied lipid classes, which might impact its properties in anticoagulation and the onset of autoimmune disease., Ramón y Cajal, Grant RYC‐2017‐21683, Ministry of Science and Innovation, Government of Spain (JLS). Generación de Conocimiento, Ministry of Science and Innovation, Government of Spain, Grant PGC2018-094894-B-I00 (JLS and EEA). Ministry of Science, Innovation and Universities of Spain (MICINN) and The European Regional Development Fund (FEDER) funding Grant RTI2018-095166-B-I00 (Antonia García y Francisco Javier Rupérez). Predoctoral Fellowship, Ministry of Universities, Government of Spain, Grant FPU19/06206 (MMG). Alejandro Urdiciain is a recipient of a Margarita Salas contract funded by UPNA and the Ministry of Universities of Spain within the Plan of Recovery, Transformation and Resilience and the European Recovery Instrument Next Generation EU.